
Can Hims & Hers Keep Outrunning the Market?
Hims & Hers Health experienced a 5.6% drop in stock price amid mixed signals from Bank of America. The company has achieved a remarkable 600% stock increase this year, driven by its semaglutide weight loss solutions. Bank of America raised the price